Amyotrophic Lateral Sclerosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
FUS and EWSR1 are RNA-binding proteins with prion-like domains (PrLDs) that aggregate in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
|
31171724 |
2019 |
Amyotrophic Lateral Sclerosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Recently, several studies have shown that missense mutations of EWSR1 genes are known to be associated with central nervous system disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
|
30481590 |
2019 |
Amyotrophic Lateral Sclerosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
<i>Cabeza</i> (<i>caz</i>) is the single <i>Drosophila melanogaster</i> orthologue of the human FET proteins FUS, TAF15, and EWSR1, which have been implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.
|
30209068 |
2018 |
Amyotrophic Lateral Sclerosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
A recent study reveals that missense mutations of <i>EWSR1</i> are associated with neurodegenerative disorders such as amyotrophic lateral sclerosis, but the function of wild-type (WT) EWSR1 in the central nervous system (CNS) is not known yet.
|
29731676 |
2018 |
Amyotrophic Lateral Sclerosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Approximately one-fifth of the PAD4 substrates contained an RG/RGG motif, and PAD4 competitively inhibited the methylation of the RGG motif in FET proteins (FUS, EWS, and TAF15) and hnRNPA1, which are causative genes for ALS (amyotrophic lateral sclerosis).
|
29425503 |
2018 |
Amyotrophic Lateral Sclerosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Among those, the FET proteins (FUS, EWSR1, TAF15) were recently identified as RNA-binding proteins in pathological inclusions of ALS and other neurodegenerative diseases; moreover, mutations in the genes encoding the FET proteins were found to be associated with familial forms of ALS.
|
27311318 |
2017 |
Amyotrophic Lateral Sclerosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Indeed, numerous RBPs with PrLDs, including TDP-43 (transactivation response element DNA-binding protein 43), FUS (fused in sarcoma), TAF15 (TATA-binding protein-associated factor 15), EWSR1 (Ewing sarcoma breakpoint region 1), and heterogeneous nuclear ribonucleoproteins A1 and A2 (hnRNPA1 and hnRNPA2), have now been connected via pathology and genetics to the etiology of several neurodegenerative diseases, including amyotrophic lateral sclerosis, frontotemporal dementia, and multisystem proteinopathy.
|
28389532 |
2017 |
Amyotrophic Lateral Sclerosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Concordant variants of particular interest were: 1) two rare, highly-conserved heterozygous non-synonymous variants in SYT9 and EWSR1, genes previously associated with ALS (out of 2044 rare heterozygous variants detected); 2) three rare homozygous missense variants; and 3) three novel copy number deletions that overlapped genes.
|
25960086 |
2015 |
Amyotrophic Lateral Sclerosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
All members of the FET family (FUS, EWS, TAF15) are co-accumulating with their nuclear import receptor Transportin in FTLD-FUS which is usually not associated with FUS mutations, whilst ALS-FUS is almost always associated with FUS mutations and reveals only FUS aggregates.
|
24011641 |
2013 |
Amyotrophic Lateral Sclerosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We identified three missense variants in EWSR1 in ALS patients, which were absent in a large number of healthy control individuals.
|
22454397 |
2012 |
Amyotrophic Lateral Sclerosis
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Postmortem analysis of sporadic ALS cases also revealed cytoplasmic mislocalization of EWSR1.
|
22454397 |
2012 |
Amyotrophic Lateral Sclerosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
|
21856723 |
2011 |